Why The FDA Panel's Nod To Sandoz's Filgrastim (Zarzio) Is Good News For Patients

The implications extend beyond cancer drugs. Biosimilars have the potential to significantly reduce the costs of modern health care for people with all kinds of illness
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news